Improving the effectiveness of routine prenatal screening for major congenital heart defects

Objective: To evaluate the effectiveness of adding outlet views to the four chamber view in routine prenatal ultrasound screening for major congenital heart defects (CHD) as performed by trained sonographers, and to compare the procedure with current practice. Design and setting: Prospective observational study at a London teaching hospital. Participants and methods: 9277 women booked at a single institution (80% had first trimester nuchal translucency measurement) due to have routine fetal cardiac screening using the four chamber and outflow tract views at > 18 weeks of gestation. Main outcome measure: Identification of major CHD in chromosomally normal and abnormal pregnancies antenatally or postnatally. Results: There were 40 abnormalities (4.3/1000), of which 30 were chromosomally normal (3.3/1000). The overall antenatal detection rate was 75% (95% confidence interval (CI) 59% to 87%) and 70% (95% CI 51% to 85%) for euploid pregnancies. Abnormal cardiac views accounted for 70% of all prenatal diagnoses, 30% of which were made at ≤ 18 weeks. The sensitivity of cardiac views during the first scan at > 18 weeks was 52%. Of all patients undergoing nuchal translucency screening, 34 had major CHD, nine with increased nuchal translucency (26.5%). Factors influencing the results of this screening programme were training and audit of operators, adequate equipment for antenatal examination, ease of access, and low threshold for referral to specialised fetal echocardiography. Conclusion: Adding ventricular outlet views to the four chamber assessment of the heart at routine fetal anomaly scans at > 18 weeks is the most effective technique to detect CHD prenatally. The success of such a programme depends on an infrastructure committed to continuous in house training of obstetric ultrasonographers coupled with feedback from specialised fetal cardiologists, as well as adequate resource allocation to obstetric hospitals involved with antenatal screening.

[1]  J Kachaner,et al.  Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality. , 1999, Circulation.

[2]  D E Grobbee,et al.  Efficacy of routine fetal ultrasound screening for congenital heart disease in normal pregnancy. , 1996, Circulation.

[3]  J I Hoffman,et al.  Congenital heart disease in a cohort of 19,502 births with long-term follow-up. , 1978, The American journal of cardiology.

[4]  K. Nicolaides,et al.  UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation , 1998, The Lancet.

[5]  R. Schiavina*,et al.  Screening for congenital heart disease with the four-chamber view of the fetal heart. , 1992, American journal of obstetrics and gynecology.

[6]  S. Zierler.  Maternal Drugs and Congenital Heart Disease , 1985, Obstetrics and gynecology.

[7]  L. Allan,et al.  Screening for congenital heart disease prenatally. Results of a 2½‐year study in the South East Thames Region , 1992 .

[8]  G. Sharland.  First-trimester transabdominal fetal echocardiography , 1998, The Lancet.

[9]  L. Chitty,et al.  Effectiveness of routine ultrasonography in detecting fetal structural abnormalities in a low risk population. , 1991, BMJ.

[10]  J. Wyllie,et al.  Prevalence and clinical significance of cardiac murmurs in neonates , 1999, Archives of disease in childhood. Fetal and neonatal edition.

[11]  K. Nicolaides,et al.  Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study , 1999, BMJ.

[12]  A. Berger.  What is fetal nuchal translucency? , 1999, BMJ.

[13]  C. Bull,et al.  Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK , 1999, The Lancet.

[14]  K. Nicolaides,et al.  Early diagnosis of major cardiac defects in chromosomally normal fetuses with increased nuchal translucency , 1999, British journal of obstetrics and gynaecology.

[15]  B. Thilaganathan,et al.  Limitations of using first‐trimester nuchal translucency measurement in routine screening for major congenital heart defects , 2001, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[16]  W. Ott.  The accuracy of antenatal fetal echocardiography screening in high- and low-risk patients. , 1995, American journal of obstetrics and gynecology.

[17]  J. Hegesh,et al.  Extended fetal echocardiographic examination for detecting cardiac malformations in low risk pregnancies. , 1992, BMJ.

[18]  G. D'ottavio,et al.  Fetal heart screening in low‐risk pregnancies , 1995, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[19]  N. Silverman,et al.  Improved Surgical Outcome After Fetal Diagnosis of Hypoplastic Left Heart Syndrome , 2001, Circulation.

[20]  V. Rose,et al.  A possible increase in the incidence of congenital heart defects among the offspring of affected parents. , 1985, Journal of the American College of Cardiology.

[21]  M. Meyer-Wittkopf,et al.  Incidence of congenital heart defects in fetuses of diabetic mothers: a retrospective study of 326 cases , 1996, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[22]  P. Brennan,et al.  Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study , 1998, The Lancet.

[23]  S. Hunter,et al.  Prenatal diagnosis of congenital heart disease in the northern region of England: benefits of a training programme for obstetric ultrasonographers , 2000, Heart.

[24]  S. Korones,et al.  Congenital Heart Disease in 56,109 Births Incidence and Natural History , 1971, Circulation.

[25]  C A Luck,et al.  Value of routine ultrasound scanning at 19 weeks: a four year study of 8849 deliveries. , 1992, BMJ.

[26]  O. J. Johansen,et al.  Prenatal detection of heart defects at the routine fetal examination at 18 weeks in a non‐selected population , 1995, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[27]  G. Sharland,et al.  Screening for congenital heart disease prenatally. Results of a 2‐year study in the South East Thames Region , 1992, British journal of obstetrics and gynaecology.

[28]  M. Tynan,et al.  Familial recurrence of congenital heart disease in a prospective series of mothers referred for fetal echocardiography. , 1986, The American journal of cardiology.

[29]  Routine radiographer screening for fetal abnormalities by ultrasound in an unselected low risk population. , 1993, The British journal of radiology.